184 related articles for article (PubMed ID: 2476115)
1. Activation of human protein C by blood coagulation factor Xa in the presence of anionic phospholipids. Enhancement by sulphated polysaccharides.
Freyssinet JM; Wiesel ML; Grunebaum L; Pereillo JM; Gauchy J; Schuhler S; Freund G; Cazenave JP
Biochem J; 1989 Jul; 261(2):341-8. PubMed ID: 2476115
[TBL] [Abstract][Full Text] [Related]
2. Interference of blood-coagulation vitamin K-dependent proteins in the activation of human protein C. Involvement of the 4-carboxyglutamic acid domain in two distinct interactions with the thrombin-thrombomodulin complex and with phospholipids.
Freyssinet JM; Beretz A; Klein-Soyer C; Gauchy J; Schuhler S; Cazenave JP
Biochem J; 1988 Dec; 256(2):501-7. PubMed ID: 2851994
[TBL] [Abstract][Full Text] [Related]
3. Effect of a pentosan polysulphate upon thrombin and factor Xa inactivation by antithrombin III.
Scully MF; Kakkar VV
Biochem J; 1984 Sep; 222(3):571-8. PubMed ID: 6207810
[TBL] [Abstract][Full Text] [Related]
4. The effect of phospholipids on the activation of protein C by the human thrombin-thrombomodulin complex.
Freyssinet JM; Gauchy J; Cazenave JP
Biochem J; 1986 Aug; 238(1):151-7. PubMed ID: 3026338
[TBL] [Abstract][Full Text] [Related]
5. The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate.
Ofosu FA; Blajchman MA; Modi GJ; Smith LM; Buchanan MR; Hirsh J
Br J Haematol; 1985 Aug; 60(4):695-704. PubMed ID: 2411283
[TBL] [Abstract][Full Text] [Related]
6. The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin.
Ofosu FA; Sie P; Modi GJ; Fernandez F; Buchanan MR; Blajchman MA; Boneu B; Hirsh J
Biochem J; 1987 Apr; 243(2):579-88. PubMed ID: 2443128
[TBL] [Abstract][Full Text] [Related]
7. Reconstitution of rabbit thrombomodulin into phospholipid vesicles.
Galvin JB; Kurosawa S; Moore K; Esmon CT; Esmon NL
J Biol Chem; 1987 Feb; 262(5):2199-205. PubMed ID: 3029069
[TBL] [Abstract][Full Text] [Related]
8. The catalytic role of anionic phospholipids in the activation of protein C by factor Xa and expression of its anticoagulant function in human plasma.
Freyssinet JM; Toti-Orfanoudakis F; Ravanat C; Grunebaum L; Gauchy J; Cazenave JP; Wiesel ML
Blood Coagul Fibrinolysis; 1991 Dec; 2(6):691-8. PubMed ID: 1799656
[TBL] [Abstract][Full Text] [Related]
9. Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells.
Ravanat C; Archipoff G; Beretz A; Freund G; Cazenave JP; Freyssinet JM
Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):7-13. PubMed ID: 1311563
[TBL] [Abstract][Full Text] [Related]
10. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.
Fischer AM; Barrowcliffe TW; Thomas DP
Thromb Haemost; 1982 Apr; 47(2):104-8. PubMed ID: 6179182
[TBL] [Abstract][Full Text] [Related]
11. The antiheparin effect of a heparinoid, pentosan polysulphate. Investigation of a mechanism.
Scully MF; Kakkar VV
Biochem J; 1984 Mar; 218(3):657-65. PubMed ID: 6202294
[TBL] [Abstract][Full Text] [Related]
12. Comparison between the effect of pentosan polysulphate heparin and antithrombin III injections in antithrombin III deficient patients.
Fischer AM; Dautzenberg MD; Aurousseau MH; Béguin S; Goudemand J; Hemker HC
Thromb Res; 1985 Jan; 37(2):295-307. PubMed ID: 2579452
[TBL] [Abstract][Full Text] [Related]
13. Localization of the inhibitory site(s) of pentosan polysulphate in blood coagulation.
Wagenvoord R; Hendrix H; Soria C; Hemker HC
Thromb Haemost; 1988 Oct; 60(2):220-5. PubMed ID: 2464199
[TBL] [Abstract][Full Text] [Related]
14. In the presence of phospholipids, glycosaminoglycans potentiate factor Xa-mediated protein C activation by modulating factor Xa activity.
McRae SJ; Stafford AR; Fredenburgh JC; Weitz JI
Biochemistry; 2007 Apr; 46(13):4195-203. PubMed ID: 17343367
[TBL] [Abstract][Full Text] [Related]
15. The activation of bovine protein C by factor Xa.
Haley PE; Doyle MF; Mann KG
J Biol Chem; 1989 Sep; 264(27):16303-10. PubMed ID: 2550435
[TBL] [Abstract][Full Text] [Related]
16. A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injection.
Fischer AM; Merton RE; Marsh NA; Williams S; Gaffney PJ; Barrowcliffe TW; Thomas DP
Thromb Haemost; 1982 Apr; 47(2):109-13. PubMed ID: 6179183
[TBL] [Abstract][Full Text] [Related]
17. Inhibition by human thrombomodulin of factor Xa-mediated cleavage of prothrombin.
Thompson EA; Salem HH
J Clin Invest; 1986 Jul; 78(1):13-7. PubMed ID: 3013935
[TBL] [Abstract][Full Text] [Related]
18. Identification of heparin cofactor II as the principal plasma cofactor for the antithrombin activity of pentosan polysulphate (SP54).
Scully MF; Kakkar VV
Thromb Res; 1984 Oct; 36(2):187-94. PubMed ID: 6209821
[TBL] [Abstract][Full Text] [Related]
19. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
Monteiro RQ; Zingali RB
Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulant activities of pentosan polysulphate (Hémoclar) due to release of hepatic triglyceride lipase (HTGL).
Barrowcliffe TW; Gray E; Merton RE; Dawes J; Jennings CA; Hubbard AR; Thomas DP
Thromb Haemost; 1986 Oct; 56(2):202-6. PubMed ID: 2433786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
